The emerging role of long non-coding RNAs in cutaneous melanoma.
Malignant melanoma is a highly aggressive form of skin cancer, the incidence of which is rising rapidly. Although MAPK-targeting therapies and immune checkpoint blockade are emerging as attractive therapeutic approaches, their utility is limited to only a subset of patients who often acquire resistance. A better understanding of the aetiologies and genetic underpinnings of melanoma is therefore critical for the development of adjuvant or alternative therapeutic strategies aimed at increasing the proportion of responders and improving treatment efficacy. A key step in identifying novel therapeutic targets may be the shift in focus from the protein-coding components to the non-coding portion of the genome. The latter, representing about 98% of the genome, serves as a template for the transcription of many thousands of long non-coding RNAs (lncRNAs). Intriguingly, lncRNA loci are frequently mutated or altered in a variety of cancers, including melanoma, and there is growing evidence that lncRNAs can function as cancer-causing oncogenes or tumour suppressors. In this review, we summarize recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets.
Laboratory for Molecular Cancer Biology, Center for the Biology of Disease, Leuven, Belgium.|Laboratory for Molecular Cancer Biology, Center of Human Genetics, Leuven, Belgium.
Eleonora
E
Leucci
Department of Biology and Biochemistry, University of Bath, Bath, UK.
Elizabeth A
EA
Coe
Laboratory for Molecular Cancer Biology, Center for the Biology of Disease, Leuven, Belgium.|Laboratory for Molecular Cancer Biology, Center of Human Genetics, Leuven, Belgium.
Jean-Christophe
JC
Marine
Department of Biology and Biochemistry, University of Bath, Bath, UK.
Keith W
KW
Vance
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D062085:RNA, Long Noncoding / Q000235:genetics*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D000096142:Cutaneous Malignant Melanoma
D014408:Biomarkers, Tumor; D062085:RNA, Long Noncoding
biomarkers; cancer therapy; cutaneous melanoma; long non-coding RNA